Public health's social contract: An obstacle in the advancement of effective HIV technologies

Global Public Health
Nicola Bulled

Abstract

Evidence from the past 40 years of HIV technology development and implementation indicates that the public health social contract - with its expectations of patient/citizen compliance - has hampered global disease control efforts. Despite the availability of a wide array of effective technologies, including antiretroviral drugs as treatment and prevention, voluntary medical male circumcision procedures, and newly developed intravaginal ring products, new infections among adults globally have not decreased significantly. In this paper, I describe a historical trend of limiting access to effective biomedical technologies to those deemed most deserving and compliant given concerns of misuse (non-adherence), product repurposing (not using the product for purposes originally intended), and the incitement of autonomy (increasing the risk of public exposure to diseases given personal protection from a specific disease). Examining the expectations of good citizenship (compliance, adherence, appropriate product use, and continued risk reduction) as it relates to human-technology interactions, reveals a continuing narrative of initially restricting access to newer technologies perceived fragile or costly based on an assessment of patient...Continue Reading

References

Aug 10, 2006·JAMA : the Journal of the American Medical Association·Edward J MillsDavid R Bangsberg
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·John A MossMarc M Baum
May 24, 2012·Journal of Pharmaceutical Sciences·Marc M BaumJohn A Moss
May 2, 2013·The Cochrane Database of Systematic Reviews·Laureen M LopezKenneth F Schulz
Jun 27, 2013·Developing World Bioethics·Nora J Kenworthy, Nicola Bulled
Aug 14, 2013·Global Public Health·Kenneth Rochel de CamargoAlain Giami
Nov 1, 2013·International Journal of Women's Health·Andrea Ries ThurmanGustavo F Doncel
Apr 12, 2014·Global Public Health·Kirsten Bell
Feb 24, 2016·The New England Journal of Medicine·Jared M BaetenUNKNOWN MTN-020–ASPIRE Study Team
Oct 21, 2016·Journal of the International AIDS Society·Gus P CairnsPedro Goicochea
Dec 14, 2016·The New England Journal of Medicine·Annalene NelUNKNOWN Ring Study Team
Aug 2, 2017·Vaccine· World Health Organization
Nov 4, 2017·The Lancet. HIV· The Lancet Hiv
Mar 21, 2018·Vaccine· World Health Organization
Jun 26, 2018·Journal of the International AIDS Society·Sarah K CalabreseJohn F Dovidio
Oct 22, 2018·The Lancet. HIV·Andrew E GrulichUNKNOWN Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group
Nov 23, 2018·Journal of the International AIDS Society·Loveleen Bansi-MatharuAndrew N Phillips
Nov 28, 2018·Current Opinion in HIV and AIDS·Asia RussellMatthew M Kavanagh

❮ Previous
Next ❯

Citations

Sep 28, 2021·Journal of the International AIDS Society·Amaya Perez-BrumerJesse L Clark

❮ Previous
Next ❯

Methods Mentioned

BETA
circumcision
medical procedure

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Academic Medicine : Journal of the Association of American Medical Colleges
A S Caelleigh
Hospitals & Health Networks
James Orlikoff
The Pharos of Alpha Omega Alpha-Honor Medical Society
D E Rogers
© 2022 Meta ULC. All rights reserved